These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4576549)

  • 1. [Clinical administration of hydralazin (Depressan) in essential and renal hypertension].
    Teichmann G; Harms R; Wedler B; Rohmann H
    Z Arztl Fortbild (Jena); 1972 Nov; 66(21):1112-6. PubMed ID: 4576549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dihydralazin treatment of hypertension during hemodialysis].
    Dzúrik R; Reznícek J; Krídl J
    Z Urol Nephrol; 1973 Dec; 66(12):907-12. PubMed ID: 4802028
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined treatment with hydrazinophthalazines and beta sympatholytic agents of nephrogenic hypertension].
    Zabicka H; Chrzanowski W; Kubala L; Orlowski Z
    Pol Tyg Lek; 1976 Dec; 31(52):2209-11. PubMed ID: 12500
    [No Abstract]   [Full Text] [Related]  

  • 4. Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.
    Glazer N
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):561-72. PubMed ID: 4628678
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hydralazine in arterial hypertension. Randomized, double-blind comparison between conventional and slow-release preparations].
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Ugeskr Laeger; 1980 Jul; 142(29):1862-5. PubMed ID: 6996259
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertensive crisis.
    Sheps SG
    Postgrad Med; 1971 May; 49(5):95-9. PubMed ID: 5577362
    [No Abstract]   [Full Text] [Related]  

  • 7. [Considerations on ambulatory therapy in a group of hypertensive patients].
    Repetto S; Rezzonico A; Gervasini N
    Minerva Med; 1969 Jun; 60(51):2550-4. PubMed ID: 5792420
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of hypotensive treatment in a hospital environment].
    Pavesi V; Campus G
    Minerva Med; 1968 May; 59(40):2345-50. PubMed ID: 5653333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with intravenous depressan ampules].
    Hennig D
    Z Urol Nephrol; 1975 Mar; 68(3):169-72. PubMed ID: 1227186
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
    Melkild A
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):148-49. PubMed ID: 6992338
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydralazine slow-release: observations on serum profile and clinical efficacy in man.
    Talseth T; Fauchald P; Pape JF
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):157-68. PubMed ID: 403050
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination therapy with alprenolol and hydralazine in essential hypertension. A controlled clinical study].
    Pape J
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1139-42. PubMed ID: 4584539
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical picture and therapy of hypertension].
    Bernsmeier A
    Munch Med Wochenschr; 1967 Sep; 109(36):1837-45. PubMed ID: 5631765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of long-term hydralazine in dilated myocardiopathies].
    Dighero H; Zepeda F; Gómez G
    Rev Med Chil; 1985 Sep; 113(9):844-9. PubMed ID: 3915581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of essential and nephrogenic hypertension using alpha-methyldopa and alpha-methyldopa+hydrochlorothiazide. Comparative study].
    Sales EJ; Villa JJ; Mendez MA
    Prensa Med Argent; 1971 Jun; 58(14):741-8. PubMed ID: 5091433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endralazine monotherapy in comparison with prazosin and hydralazine in arterial hypertension].
    Postol'nikov SF; Izotov AI; Malysheva NV
    Sov Med; 1986; (10):86-9. PubMed ID: 3544243
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypotensive effect of methyldopa in renal failure associated with hypertension.
    Stenbaek O; Myhre E; Brodwall EK; Hansen T
    Acta Med Scand; 1972 Apr; 191(4):333-7. PubMed ID: 5032677
    [No Abstract]   [Full Text] [Related]  

  • 18. Once daily slow-release hydralazine in hypertension.
    O'Boyle CP; Kelly J; O'Brien ET; O'Malley K
    Ir Med J; 1981 Apr; 74(4):115-6. PubMed ID: 7228629
    [No Abstract]   [Full Text] [Related]  

  • 19. Slow-release metoprolol, hydrochlorothiazide and hydralazine in stepwise treatment of essential hypertension.
    Houtzagers JJ; Dols DM; Meems L
    Neth J Med; 1984; 27(8):287-92. PubMed ID: 6504227
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B; Wendt G
    Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.